PF-07832837 Clinical Trials (2026): 1 Studies for Atopic Dermatitis & Healthy Participants
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 PF-07832837 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Atopic Dermatitis & Healthy Participants) and 119 total planned enrollment. 1 PF-07832837 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT06564389 (Jun 2027).
Where to Participate: All PF-07832837 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting PF-07832837trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Anaheim Clinical Trials, LLC | Anaheim92801 | NCT06564389 | Map |
PF-07832837 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting PF-07832837 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06564389 | FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients | P1 | Healthy Participants | 119 | Nov 2024 |
All PF-07832837 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06564389 | FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients | P1 | recruiting | 119 | Pfizer | Nov 2024 |
PF-07832837 clinical trials: frequently asked questions
- How many PF-07832837 clinical trials are there?
- 1 PF-07832837 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are PF-07832837 clinical trials recruiting in 2026?
- Yes — 1 PF-07832837 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is PF-07832837 being studied for?
- PF-07832837 is being studied for Atopic Dermatitis, Healthy Participants. The trials are grouped by indication on this page.
- What phase is PF-07832837 in?
- PF-07832837 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors PF-07832837 clinical trials?
- The lead sponsor across the most PF-07832837 trials is Pfizer. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming PF-07832837as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: